In comparisons to both healthy controls and other primary immunodeficiencies (PIDs) including NCF1/NCF2 mutant CGD, we defined the gp91 expression level in patients with X91+ as > 70%, X91− as 5–70%, and X910 as < 5%. The gene discussed is NCF2; the disease is inborn error of immunity.